Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04302454
Title Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy (ADOPT)
Acronym ADOPT
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors University Medical Center Groningen
Age Groups: adult | senior
Covered Countries NLD

No variant requirements are available.